» Articles » PMID: 6134180

Gradual Withdrawal of Diazepam After Long-term Therapy

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1983 Jun 25
PMID 6134180
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

41 outpatients who were long-term consumers of diazepam in therapeutic dosage were gradually withdrawn from the drug over 3 months by stepwise reduction. In a double-blind procedure half the patients began withdrawal immediately and half after 8 weeks. Of 36 patients who completed treatment, 16 (44.4%) experienced true withdrawal phenomena on reducing their drugs, but 8 other patients had pseudo-withdrawal reactions at a time when their drug treatment was unchanged. The pseudo-withdrawal reactions consisted of an increase in anxiety symptoms only, whereas true withdrawal symptoms also included perceptual changes and psychotic symptoms. Examination of pharmacological and clinical predictors of withdrawal phenomena and later relapse showed that personality factors were the most important, patients with passive-dependent traits having a significantly greater prevalence of withdrawal reactions.

Citing Articles

Management of chronic insomnia using hypnotics: a friend or a foe?.

Basu A, Joshi T, Pal A, Gupta R Sleep Biol Rhythms. 2024; 20(1):39-46.

PMID: 38469060 PMC: 10900020. DOI: 10.1007/s41105-021-00363-4.


Surviving Benzodiazepines: A Patient's and Clinician's Perspectives.

Silvernail C, Wright S Adv Ther. 2022; 39(5):1871-1880.

PMID: 35239167 PMC: 9056465. DOI: 10.1007/s12325-022-02055-y.


Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders.

Chapoutot M, Peter-Derex L, Bastuji H, Leslie W, Schoendorff B, Heinzer R Int J Environ Res Public Health. 2021; 18(19).

PMID: 34639523 PMC: 8508349. DOI: 10.3390/ijerph181910222.


Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review.

Wright S Adv Ther. 2020; 37(6):2604-2619.

PMID: 32378069 PMC: 7467435. DOI: 10.1007/s12325-020-01354-6.


Effect of Genetic Information and Information About Caffeine Content on Caffeine Withdrawal Symptoms.

Mills L, Dar-Nimrod I, Colagiuri B Sci Rep. 2017; 7(1):8407.

PMID: 28827535 PMC: 5566379. DOI: 10.1038/s41598-017-08678-4.